SG&A expenses increased $1.8 million, or 9%, to $22 million compared to the prior year period. This change was driven by a $1.3 million increase in compensation expenses, mainly as a result of increased headcount, a $0.5 million increase in advertising expense, and a $0.3 million increase in travel expense, partially offset by a $0.3 million decrease in consulting expense.

Feb 12, 2026 / receipt, needs a key / Jared O'Shine, CFO | earnings call 2026-02-12 | transcript ad37f876-7c27-46a1-a4c1-cfe7a4540793 | chars 13615-13990 | segment 13

Q4 is typically a lighter order when it comes to trade show and marketing spend. And so we would typically see a little fewer dollars going into that bucket in the fourth quarter as compared to the third.

Nov 5, 2025 / receipt, needs a key / Jared, CFO | earnings call 2025-11-05 | transcript b42b42d7-edf7-4446-a51d-c4cdf402c4ac | chars 32583-32787 | segment 33

SG&A expenses increased $0.2 million, or 1%, to $21.9 million for the three months ended September 30, 2025, compared to the three months ended September 30, 2024. This change was primarily driven by a $0.2 million increase in consulting expenses, a $0.2 million increase in travel expenses, and a $0.2 million increase in non-cash stock-based compensation expense.

Nov 5, 2025 / receipt, needs a key / Jared O'Shine, CFO | earnings call 2025-11-05 | transcript b42b42d7-edf7-4446-a51d-c4cdf402c4ac | chars 9485-9850 | segment 9

This change was primarily driven by a $1.4 million increase in compensation expenses, a $0.8 million increase in travel expenses, and a $0.4 million increase in non-cash stock-based compensation expense, partially offset by a $0.5 million decrease in advertising expenses.

Aug 4, 2025 / receipt, needs a key / Jared O'Shine, CFO | earnings call 2025-08-04 | transcript 62b03b30-5b3f-48d4-b628-6fa0fbf6778f | chars 11946-12218 | segment 12

SG&A expenses for the fourth quarter were $20.2 million, representing a 19% increase compared to the same period last year. This change was driven by a $2.9 million increase in compensation expenses, mainly as a result of increased headcount, a $1 million increase in non-cash stock-based compensation expense, and a $0.3 million increase in travel expenses, partially offset by a $1.1 million decrease in advertising expenses.

Feb 4, 2025 / receipt, needs a key / Jared O'Shine, CFO | earnings call 2025-02-04 | transcript 0be1e121-d965-4d8e-8484-25fe4882b022 | chars 8322-8749 | segment 8

SG&A expenses increased $6 million, or 38%, to $21.6 million for the three months ended September 30, 2024, compared to the three months ended September 30, 2023. This change was primarily driven by a $3.7 million increase in compensation expenses, mainly as a result of increased headcount, a $1.1 million increase in non-cash stock-based compensation expense, a $0.5 million increase in travel expenses, and a $0.4 million increase in advertising expenses.

Oct 29, 2024 / receipt, needs a key / Jared O'Shaughnessy, CFO | earnings call 2024-10-29 | transcript a4abc307-bba2-4eda-b434-fc213e1f5857 | chars 11955-12413 | segment 11

SG&A expenses for the current quarter were $21.1 million, representing an increase of 28% compared to the same period last year. This change was primarily driven by a $2.6 million increase in compensation expenses, mainly as a result of increased headcount, a $1 million increase in non-cash stock-based compensation expense, a $0.4 million increase in advertising expenses, a $0.2 million increase in travel expenses, and a $0.2 million increase in consulting expenses.

Jul 29, 2024 / receipt, needs a key / Jared O'Shaughnessy, CFO | earnings call 2024-07-29 | transcript a25825ba-c77a-41e5-925f-481e70192662 | chars 11410-11880 | segment 11

SG&A expenses for the current quarter were $28.3 million, representing an increase of 84% compared to the same period last year. This change was primarily driven by a $9.6 million increase in non-cash stock-based compensation expense, a $2 million increase in compensation expense, and a $0.6 million increase in travel expenses.

Apr 30, 2024 / receipt, needs a key / Jared O'Shine, CFO | earnings call 2024-04-30 | transcript 253627b3-d6ac-45c6-99d7-38ae942d5195 | chars 14679-15008 | segment 14

This change was primarily driven by a $1.9 million increase in compensation expenses, mainly as a result of increased headcount, a $0.5 million increase in non-cash stock-based compensation expense, a $0.3 million increase in marketing and advertising expenses associated with the commercialization of Barro Stem in the U.S., and a $0.1 million increase in travel expenses.

Oct 26, 2023 / receipt, needs a key / Jared Oshheim, CFO | earnings call 2023-10-26 | transcript fb077014-5e92-465b-8da7-0f6638ed5168 | chars 8024-8397 | segment 8

We often see some additional spend related to trade shows in our sales and marketing line.

Oct 26, 2023 / receipt, needs a key / Nadeem Yared, CEO | earnings call 2023-10-26 | transcript fb077014-5e92-465b-8da7-0f6638ed5168 | chars 22279-22369 | segment 22

SG&A expenses for the current quarter were $16.5 million, representing an increase of 32% compared to the same period last year. This change was primarily driven by a $2.5 million increase in compensation expenses, mainly as a result of increased headcount, a $0.8 million increase in marketing and advertising expenses associated with the commercialization of Barro Stem in the U.S., a $0.4 million increase in travel expenses, and a $0.3 million increase in non-cash stock-based compensation expense.

Jul 25, 2023 / receipt, needs a key / Jared Oshime, CFO | earnings call 2023-07-25 | transcript 604d6024-ce6d-4fcb-ab97-cec1ab3bbc4f | chars 8277-8779 | segment 8

This increase was mainly driven by higher compensation expenses due to increased headcount. as well as increases in travel expenses, non-cash stock-based compensation expenses, and marketing and advertising expenses related to the commercialization of Barrow Stem.

Apr 27, 2023 / receipt, needs a key / Jared O'Shine, CFO | earnings call 2023-04-27 | transcript 58aca1fa-37f1-4dd8-8eff-472268488c63 | chars 7066-7330 | segment 7